Multifunctional Nanocomposites for Targeted, Photothermal, and Chemotherapy

In the past decades, advances in nanoparticles (NPs) synthesis and engineering have greatly propelled the application of nanoscale agents for therapeutic and diagnostic functions, promoting an emerging field of “nanotheranostics”. In particular, they are being increasingly exploited for cancer management, in which diagnosis and therapy are combined to address clinical challenges. In this work, core–shell-structured amorphous zinc oxide (a-ZnO) on gold NPs (Au-His@a-ZnO) was produced using histidine (His) to control the shell growth under hydrothermal conditions. Subsequently, Au-His@a-ZnO NPs were integrated onto the planar structure of PEGylated graphene oxide (PEG-GO) via carbodiimide cross-linker chemistry. More importantly, strong absorption and near-infrared (NIR) emission in the range of 700 to 900 nm was observed with preferential uptake at tumors and high photothermal conversion efficiency (η = 38%). Both in vitro and in vivo studies showed that the GO@Au-His@a-ZnO NCs were biocompatible with low toxicity. Moreover, GO@Au-His@a-ZnO NCs were further conjugated with the antibody of epidermal growth factor receptor aptamer (anti-EGFR Apt) and doxorubicin (DOX), yielding Apt@GO@Au-His@a-ZnO@DOX NCs, which were then applied toward the synergetic treatment of lung cancer. The prepared Apt@GO@Au-His@a-ZnO@DOX NCs showed a high loading capacity of DOX, as well as NIR/pH-sensitive drug release in which the metal–drug complex dissociated to release antitumor Zn2+ ions into the acidic endosome/lysosome. In addition, these materials also showed good biostability and anti-EGFR Apt-promoted binding specificity for lung cancer cells. The specific binding facilitated the cellular uptake into EGFR-mutated cancer sites, as compared with nontargeted controls. In particular, human pulmonary adenocarcinoma cell (A549)-tumor bearing mice were selected as the animal model, and efficient targeted drug delivery and the high anticancer efficacy of Apt@GO@Au-His@a-ZnO NCs in vivo were demonstrated. Taken together, our multifunctional NCs, Apt@GO@Au-His@a-ZnO@DOX NCs, have shown high efficacy in targeted, photothermal, and chemotherapy when applied to lung cancer. This proof-of-principle example suggests a fascinating perspective for these functional NCs for future clinical use.